Tech Company Financing Transactions

RETINA-AI Health Funding Round

On 8/10/2020, RETINA-AI Health secured $5.2 million in Series A funding from private investors.

Transaction Overview

Company Name
Announced On
8/10/2020
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Series A
Investors

private investors (William Smith)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2925 Richmond Ave. 1200
Houston, TX 77098
USA
Email Address
Overview
RETINA-AI Health, Inc. has developed artificial intelligence technology to enable the diabetic retinal exam to be done in the primary care setting. The company's HUMMINGBIRD DR 100 is a cloud-based AI detector of diabetic retinopathy which interprets the retinal image and returns a PDF report within a few seconds.
Profile
RETINA-AI Health LinkedIn Company Profile
Social Media
RETINA-AI Health Company Twitter Account
Company News
RETINA-AI Health News
Facebook
RETINA-AI Health on Facebook
YouTube
RETINA-AI Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Odaibo
  Stephen Odaibo LinkedIn Profile  Stephen Odaibo Twitter Account  Stephen Odaibo News  Stephen Odaibo on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/10/2020: HyperQube Technologies venture capital transaction
Next: 8/10/2020: Artemest venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary